ARCHIVES

Bonadonna’s Study At Four Years: CMF Group Still Doing Better

This article is from The Cancer Letter archive.

Vol. 04 No. 47 | November 24, 1978

Download PDF Visit The Full Archive

Related Articles

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

In Brief: Bailes Succeeds Lichor As ASCO President; Einhorn Is President-Elect; Durant Honored

May 21, 1999

Mammography’s Best Role Is Screening, Kopans Assert

March 18, 1994

William Nelson Named Cancer Center Director At Johns Hopkins.

November 7, 2008

CIDAC Bids Not Limited To Cancer Research Centers

January 17, 1975

The President’s Cancer Panel publishes its annual report

May 6, 2011